Apremilast for oral ulcers associated with active Behçet's syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial
Gülen Hatemi, Alfred Mahr, Mitsuhiro Takeno, Do Young Kim, David Saadoun, Haner Di̇reskeneli̇, Melike Melikoğlu, Sue Cheng, Shannon McCue, Maria Paris, Mindy Chen, Yusuf Yazıcı
Abstract
International audience
Topics & Concepts
ApremilastMedicinePlaceboAdverse effectDiscontinuationInternal medicineNauseaClinical endpointRandomized controlled trialDiseasePsoriatic arthritisAlternative medicinePathologyOcular Diseases and Behçet’s SyndromeOtitis Media and Relapsing PolychondritisDrug-Induced Adverse Reactions